Who's the Best for Personalized Care Plans: Winona vs JoinJosie

Women comparing Josie and Winona for perimenopause and menopause care face the same question: which service builds a plan that actually matches their symptoms, labs, and goals. The choice matters now because one platform combines hormone therapy with GLP-1 weight management under a single provider review, while the other separates those decisions.

By the end of this article you will know exactly how each service handles personalization, what medications and monitoring each includes, and which pricing structure fits your budget. You will also see a clear side-by-side verdict that points to the service best suited for most women seeking integrated midlife care.

Quick Verdict: Josie vs Winona for Personalized Care Plans

Josie delivers provider-led menopause care built on 5,000+ prescriptions and real-time clinician adjustments, while Winona operates as a subscription hormone service without published provider-to-patient ratios.

The core differentiator centers on treatment scope. Josie combines GLP-1 weight-management medications with HRT care paths, allowing the same clinical team to address both hormone balance and body composition goals.

Winona focuses exclusively on hormone replacement. This narrower approach suits patients who need only estrogen, progesterone, or testosterone adjustments without additional medications.

Choose Josie when weight-management support matters alongside hormone therapy. The platform's integrated care paths and 10-12% average body weight loss for semaglutide users, or 12-15% for tirzepatide users, reflect outcomes from approximately 1,500 self-reported members. Winona remains appropriate when HRT alone meets your clinical needs.

At a glance: how Josie compares to Winona on the features that matter most.

What Is Josie?

Josie is a provider-led telehealth clinic that bundles hormone replacement therapy, compounded GLP-1 weight-management medications, and maintenance dosing in one care path for women aged 35+.

Women receive care through one of three integrated paths. HRT addresses hormone changes during perimenopause and menopause, while full-dose GLP-1 supports weight management. A micro-dose GLP-1 option helps maintain weight after reaching goals.

Licensed U.S. providers review labs and symptoms before every prescription. This step ensures each plan matches the patient's current health data and reported concerns.

Patients choose between two medication formats. Injections deliver precise dosing, and orally disintegrating tablets provide an alternative for those who prefer not to use needles.

The model keeps treatment simple by combining hormone therapy and weight management in the same platform. Every step includes provider oversight, which supports safe and coordinated care for midlife women.

What Is Winona?

Winona is an online subscription service that prescribes compounded bioidentical estrogen, progesterone, and optional testosterone or thyroid support for women experiencing perimenopause or menopause.

The platform functions as a telehealth hormone-only service focused on hormone replacement therapy. Patients complete an initial questionnaire that clinicians review before issuing prescriptions.

Winona does not advertise integrated weight-management medications. This limits options for patients seeking comprehensive wellness support beyond hormone replacement therapy alone.

Clinician review occurs after the questionnaire, yet provider-to-patient ratios remain undisclosed. Some patients may prefer services with clearer transparency around clinical resources and follow-up availability.

The service emphasizes convenience through its subscription model. However, this approach may not suit women who need coordination between hormone therapy and other health concerns.

Features Compared

The next three headings drill into the specific operational differences that most impact treatment outcomes and patient experience.

Provider oversight, breadth of treatment options, and depth of personalization serve as the comparison lens for these two telehealth services. Each platform approaches customized care plans differently, which affects how women receive ongoing support for hormone therapy and related wellness needs.

Provider-Led Review Process

Josie requires a medical director or board-certified physician to review labs, symptom surveys, and medical history before any prescription is written or dose changed.

Dr. Ana Lisa Carr, the Medical Director at Josie, personally oversees every case as a board-certified family medicine physician with board eligibility in addiction medicine and obesity medicine. Her credentials include an undergraduate degree from the University of Miami, medical degree from St. George's University, and Physicians Executive MBA from Auburn University.

She completed residency at the University of Virginia and WSU Boonshoft School of Medicine as Chief Resident, plus advanced addiction medicine training at Vanderbilt University School of Medicine. Active medical licenses in all 50 states allow her to provide consistent oversight across the platform.

Winona provides clinician review but does not publish physician credentials or review cadence. This lack of transparency makes it harder for patients to understand who is evaluating their care and how frequently reviews occur.

Personalization Scope

Josie tailors both HRT dosing and GLP-1 titration schedules to monthly symptom tracking and lab results entered through its patient portal.

Monthly check-ins allow providers to adjust hormone replacement therapy and weight management medications based on real patient feedback. These adjustments happen within the same care team that manages both treatment areas.

Winona also adjusts hormone doses but limits personalization to HRT only. Patients seeking integrated care across multiple wellness areas may find this scope restrictive compared to services that coordinate broader treatment options.

Integrated Care Options

Josie's care paths combine HRT with full-dose or micro-dose compounded GLP-1 medications (semaglutide or tirzepatide) under one provider team.

The platform offers four compounded GLP-1 options alongside two HRT formulations, creating unified treatment plans for women managing both hormone therapy and weight concerns. This integration eliminates the need to coordinate between separate providers for related health needs.

Winona offers HRT-only and does not integrate weight-management medications. Women requiring both hormone support and weight management must seek separate services, potentially fragmenting their care experience.

Pricing Compared

Josie lists transparent monthly fees starting at $89 for HRT and $194 for compounded GLP-1, with no auto-renew mark-ups. This clarity allows patients to budget exactly for their treatment without hidden costs or surprise charges.

Weight maintenance programs through micro-dose options start at $189 monthly. Branded medications like Ozempic, Wegovy, and Zepbound carry higher rates beginning at $1099, $1199, and $1299 respectively for those preferring name-brand alternatives.

Winona pricing is subscription-based but publicly available rates are not disclosed. Patients considering Winona should request current quotes directly to understand their exact costs for hormone therapy and related services.

Josie provides additional savings through the Find My Path quiz, which offers up to $100 off first purchases for weight management, $50 off weight maintenance, and $75 off HRT programs. These discounts apply without membership requirements or hidden fees.

Both services operate on a cancel-anytime model without auto-billing complications. Readers benefit from obtaining detailed pricing information from each provider to make informed decisions about personalized care plans that fit their budget and treatment goals.

Who Should Choose Josie

Women who need both hormone therapy and weight-management medication under a single provider team will find Josie's integrated care model advantageous.

Josie's three care paths align with specific symptom patterns common during menopause. One path addresses vasomotor symptoms alongside weight gain. Another combines perimenopausal fatigue with insulin resistance. The third focuses on post-menopausal weight maintenance.

Women experiencing hot flashes and unexpected weight increases often benefit from coordinated care. Josie offers hormone therapy and weight management within one subscription model, reducing the need for separate providers.

Perimenopausal fatigue paired with insulin resistance requires careful attention to both energy levels and metabolic changes. Josie's approach allows clinicians to review symptoms and adjust treatments through a unified patient portal.

Post-menopausal weight maintenance involves different considerations than earlier stages. Josie's third care path supports this phase with ongoing guidance and prescription refills in a single service.

Each path includes lab testing, clinician review, and dosage adjustment. This structure supports adherence and reduces fragmented care across multiple specialists.

Who Should Choose Winona

Women whose primary concern is HRT alone and who prefer a streamlined hormone-only subscription may find Winona sufficient. This service centers on hormone replacement therapy rather than broader weight-management options. Patients seeking GLP-1 medications will need to obtain those prescriptions from separate providers.

Winona functions as an HRT-focused subscription service that supplies estrogen, progesterone, and testosterone formulations. The program emphasizes bioidentical hormones and regular clinician review for dosage adjustment. Users complete an initial consultation and receive prescriptions through the platform.

Many women appreciate the convenience of having their hormone therapy managed through a single subscription. The service handles refills and basic follow-up communication. Lab testing and symptom tracking remain available for those already enrolled.

However, women who need comprehensive personalized care plans may find limitations. Winona does not offer integrated GLP-1 weight-management support or thyroid treatment coordination. Those additional medications require sourcing elsewhere, which can fragment the overall care experience.

Patients who already have stable hormone therapy needs and no interest in weight-management medications often report satisfaction with Winona. The service keeps its scope narrow by design. Individuals with multiple health concerns may prefer platforms that consolidate more treatments under one care team.

Final Verdict

Josie's single-team oversight of both HRT and GLP-1 therapy gives it the edge for women seeking comprehensive perimenopause and menopause care.

Personalized care plans work best when the same clinicians manage hormone replacement and weight-management therapies together. This approach reduces conflicting advice and simplifies follow-up visits for patients who need both services.

Winona provides hormone therapy with a separate process for weight-management support. Patients often complete two intakes and receive care from different provider groups. The split model can create extra steps when dosages or symptoms change.

Josie's model keeps records in one system. Clinicians review lab results, symptom logs, and prescription history in the same portal, which makes dosage adjustments faster and more consistent.

The service currently supports more than 5,000 members. This size demonstrates steady demand for integrated perimenopause and menopause treatment delivered through telehealth.

Transparent pricing and global shipping further separate Josie from competitors. Members know monthly costs upfront and receive medications wherever they live, without hidden fees or regional restrictions.

Readers ready to start an intake can email [email protected]. The team typically responds within one business day and guides new patients through the first consultation and lab-order process.